We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+18.35%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$11.6B
AUM Growth
+$1.31B
Cap. Flow
+$110M
Cap. Flow %
0.94%
Top 10 Hldgs %
19.9%
Holding
462
New
101
Increased
148
Reduced
98
Closed
87

Top Sells

Rank Stock Value
1
CAMT icon
Camtek
CAMT
+$168M
2
CCJ icon
Cameco
CCJ
+$126M
3
ELF icon
e.l.f. Beauty
ELF
+$100M
4
SMCI icon
Super Micro Computer
SMCI
+$96.7M
5
ONTO icon
Onto Innovation
ONTO
+$88.5M

Sector Composition

Rank Sector Weight
1 Healthcare 24.79%
2 Industrials 19.06%
3 Technology 18.73%
4 Consumer Discretionary 12.67%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHYF
276
DELISTED
The Shyft Group
SHYF
$5.21M 0.04%
+414,965
New +$5.34M
AAPL icon
277
Apple
AAPL
$4.46T
$5.19M 0.04%
22,290
+80
+0.4% +$17.9K
KRRO icon
278
Korro Bio
KRRO
$155M
$5.16M 0.04%
154,495
+37,637
+32% +$1.58M
AXGN icon
279
Axogen
AXGN
$2.46B
$5.03M 0.04%
+358,860
New +$3.97M
VERA icon
280
Vera Therapeutics
VERA
$2.31B
$4.72M 0.04%
106,815
-148,318
-58% -$5.63M
APG icon
281
APi Group
APG
$17.2B
$4.52M 0.04%
205,256
-2,071,644
-91% -$48.6M
PLOW icon
282
Douglas Dynamics
PLOW
$972M
$4.5M 0.04%
+163,119
New +$4.3M
PENN icon
283
PENN Entertainment
PENN
$2.67B
$4.42M 0.04%
234,289
WWW icon
284
Wolverine World Wide
WWW
$1.62B
$4.39M 0.04%
+252,092
New +$3.49M
TVTX icon
285
Travere Therapeutics
TVTX
$5.11B
$4.38M 0.04%
+313,242
New +$3.26M
NGNE icon
286
Neurogene
NGNE
$656M
$4.29M 0.04%
102,187
NVDA icon
287
NVIDIA
NVDA
$5.01T
$4.29M 0.04%
35,293
+2,337
+7% +$276K
ML
288
DELISTED
MoneyLion Inc.
ML
$3.68M 0.03%
88,638
-132,850
-60% -$7.2M
CZR icon
289
Caesars Entertainment
CZR
$6.06B
$3.49M 0.03%
83,666
MSFT icon
290
Microsoft
MSFT
$3.62T
$3.41M 0.03%
7,918
-2,409
-23% -$1.03M
KSPI icon
291
Kaspi.kz JSC
KSPI
$17.5B
$3.4M 0.03%
32,075
+10,064
+46% +$1.25M
CLYM
292
Climb Bio
CLYM
$676M
$3.12M 0.03%
612,387
-83,670
-12% -$592K
CHT icon
293
Chunghwa Telecom
CHT
$32.9B
$3.12M 0.03%
78,571
CRBP icon
294
Corbus Pharmaceuticals
CRBP
$165M
$2.64M 0.02%
127,787
+64,728
+103% +$3.31M
ONC
295
BeOne Medicines Ltd
ONC
$32.6B
$2.6M 0.02%
11,582
+3,397
+42% +$611K
SKYE icon
296
Skye Bioscience
SKYE
$20.5M
$2.54M 0.02%
650,758
BDTX icon
297
Black Diamond Therapeutics
BDTX
$99.7M
$2.41M 0.02%
555,111
-50,790
-8% -$276K
META icon
298
Meta Platforms (Facebook)
META
$1.5T
$2.38M 0.02%
4,158
+750
+22% +$386K
GAUZ
299
Gauzy
GAUZ
$5.23M
$2.36M 0.02%
266,565
-90,263
-25% -$918K
ADPT icon
300
Adaptive Biotechnologies
ADPT
$3.68B
$2.23M 0.02%
+435,294
New +$1.9M

Similar funds

Driehaus Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Driehaus Capital Management held 462 positions worth $11.6B, up 13% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Driehaus Capital Management's Q3 2024 filing shows 101 new, 148 increased, 98 reduced and 87 closed positions. Its largest new stake was Varonis Systems: 1,349,464 shares worth $76.2M. The largest sale was Camtek, an estimated $168M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

  • Driehaus Capital Management's largest Q3 2024 buy was Varonis Systems: 1,349,464 shares worth $76.2M.
  • Driehaus Capital Management added most to Mercado Libre in Q3 2024, an estimated $60.8M increase.
  • Driehaus Capital Management's biggest Q3 2024 reduction was Cameco, cutting an estimated $126M.
  • Driehaus Capital Management fully exited Camtek in Q3 2024, selling an estimated $168M.
  • Driehaus Capital Management's ten largest holdings make up 20% of its $11.6B portfolio in Q3 2024.
  • Driehaus Capital Management opened 101 new positions and closed 87 in Q3 2024.
  • Driehaus Capital Management's portfolio value rose 13% quarter-over-quarter to $11.6B.

Based on Driehaus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.